Mechanism of CPNE3 regulating proliferation, migration and invasion of non-small cell lung cancer cells
Progress and prospect of epidermal growth factor receptor tyrosine kinase inhibitor in treatment of non-small cell lung cancer
Predictive value of clinical parameters in responses to epidermal growth factor-tyrosine kinase inhibitors as first-line therapy for stage Ⅳ non-small cell lung cancer
Related Author
史建涛
储卫华
孟辉
林江凯
冯华
朱宇熹
陈绪元
骆云鹏
Related Institution
Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Diseases, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Provmce
Department of Respiratory and Critical Care Medicine, Shulan (Hangzhou) Hospital
Cancer Institute, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Epidemiology, Faculty of Military Preventive Medicine, Army Medical University(Third Military Medical University)
Department of Thoracic Surgery, Second Affiliated Hospital of Army Medical University (Third Military Medical University)